(Press-News.org) Contact information: David McKeon
DMckeon@nyscf.org
212-365-7440
New York Stem Cell Foundation
NYSCF scientists make living brain cells from Alzheimer's patients biobanked brain tissue
New study shows ability to make living human cells from biobanked brain tissue
NEW YORK, NY (January 7, 2014) – Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute, working in collaboration with scientists from Columbia University Medical Center (CUMC), for the first time generated induced pluripotent stem (iPS) cells lines from non-cryoprotected brain tissue of patients with Alzheimer's disease.
These new stem cell lines will allow researchers to "turn back the clock" and observe how Alzheimer's develops in the brain, potentially revealing the onset of the disease at a cellular level long before any symptoms associated with Alzheimer's are displayed. These reconstituted Alzheimer's cells will also provide a platform for drug testing on cells from patients that were definitively diagnosed with the disease. Until now, the only available method to definitively diagnose Alzheimer's disease that has been available to researchers is examining the brain of deceased patients. This discovery will permit scientists for the first time to compare "live" brain cells from Alzheimer's patients to the brain cells of other non-Alzheimer's patients.
NYSCF scientists successfully produced the iPS cells from frozen tissue samples stored for up to eleven years at the New York Brain Bank at Columbia University.
This advance, published today in Acta Neuropathologica Communications , shows that disease-specific iPS cells can be generated from readily available biobanked tissue that has not been cryoprotected, even after they have been frozen for many years. This allows for the generation of iPS cells from brains with confirmed disease pathology as well as allows access to rare patient variants that have been banked. In addition, findings made using iPS cellular models can be cross-validated in the original brain tissue used to generate the cells. The stem cell lines generated for this study included samples from patients with confirmed Alzheimer's disease and four other neurodegenerative diseases.
This important advance opens up critical new avenues of research to study cells affected by disease from patients with definitive diagnoses. This success will leverage existing biobanks to support research in a powerful new way.
iPS cells are typically generated from a skin or blood sample of a patient by turning back the clock of adult cells into pluripotent stem cells, cells that can become any cell type in the body. While valuable, iPS cells are often generated from patients without a clear diagnosis of disease and many neurodegenerative diseases, such as Alzheimer's disease, often lack specific and robust disease classification and severity grading. These diseases and their extent can only be definitively diagnosed by post-mortem brain examinations. For the first time we will now be able to compare cells from living people to cells of patients with definitive diagnoses generated from their banked brain tissue.
Brain bank networks, which combined contain tens of thousands of samples, provide a large and immediate source of tissue including rare disease samples and a conclusive spectrum of disease severity among samples. The challenge to this approach is that the majority of biobanked brain tissue was not meant for growing live cells, and thus was not frozen in the presence of cryoprotectants normally used to protect cells while frozen. NYSCF scientists in collaboration with CUMC scientists have shown that these thousands of samples can now be used to make living human cells for use in disease studies and to develop new drugs or preventative treatments for future patients.
###
NYSCF stem cell researcher Scott Noggle, PhD, the Charles Evans Senior Research Fellow for Alzheimer's Disease and CUMC physician-scientist John Crary, MD, PhD, are the senior authors and NYSCF researchers Andrew Sproul, PhD, and Lauren Vensand are the co-first authors of this study.
The New York Stem Cell Foundation research was supported by the Cure Alzheimer's Fund, Charles Evans Foundation, and The New York Stem Cell Foundation. The Columbia University Medical Center research was funded by the Alzheimer's Association (NIRG-11-204450), the Louis V. Gerstner, Jr., Foundation, and The American Recovery and Reinvestment Act (ARRA) funds through Grant number P30AG036453.
About The New York Stem Cell Foundation
The New York Stem Cell Foundation (NYSCF) is an independent organization founded in 2005 to accelerate cures and better treatments for patients through stem cell research. NYSCF employs over 45 researchers at the NYSCF Research Institute, located in New York, and is an acknowledged world leader in stem cell research and in developing pioneering stem cell technologies, including the NYSCF Global Stem Cell ArrayTM. Additionally, NYSCF supports another 60 researchers at other leading institutions worldwide through its Innovator Programs, including the NYSCF – Druckenmiller Fellowships and the NYSCF – Robertson Investigator Awards. NYSCF focuses on translational research in a model designed to overcome the barriers that slow discovery and replaces silos with collaboration.
NYSCF researchers have achieved six major discoveries in the field, including: the first stem cell-derived beta cell model that accurately reflects the features of a genetic form of diabetes in June 2013; the generation of functional, immune-matched bone substitutes from patients' skin cells (featured in The Wall Street Journal in May 2013); the discovery of a clinical cure to prevent transmission of maternally inherited mitochondrial diseases in December 2012; the derivation of the first-ever patient specific embryonic stem cell line (#1 Medical Breakthrough of 2011 by Time magazine); the discovery of a new way to reprogram stem cells; and, the creation of the first disease model from induced pluripotent stem cells (also named the #1 Medical Breakthrough by Time magazine in 2008). More information is available at http://www.nyscf.org.
NYSCF scientists make living brain cells from Alzheimer's patients biobanked brain tissue
New study shows ability to make living human cells from biobanked brain tissue
2014-01-07
ELSE PRESS RELEASES FROM THIS DATE:
Some brain regions retain enhanced ability to make new connections
2014-01-07
Some brain regions retain enhanced ability to make new connections
In adults, some brain regions retain a "childlike" ability to establish new connections, potentially contributing to our ability to learn new skills and form new memories as we age, ...
Several forms of vitamin E protect against memory disorders
2014-01-07
Several forms of vitamin E protect against memory disorders
Elderly people with high serum vitamin E levels are less likely to suffer from memory disorders than their peers with lower levels, according to a study published recently in Experimental ...
Patterns of social interaction remain consistent over time
2014-01-07
Patterns of social interaction remain consistent over time
The research was conducted by researchers form Aalto University and University of Oxford, and was published in Proceedings of the National Academy of Sciences of the United States of America (PNAS) recently.
"We ...
The power of packaging in consumer choices
2014-01-07
The power of packaging in consumer choices
Researchers from the University of Miami and California Institute of Technology show how the brain considers both visual cues and taste preferences when making everyday food choices
CORAL GABLES, FL (January 6, 2014) — ...
By the numbers: A simple 10 step approach to reducing the harms of alcohol
2014-01-07
By the numbers: A simple 10 step approach to reducing the harms of alcohol
London, LA (07 January 2013). Much the same way individuals are encouraged to know their blood pressure and cholesterol numbers to maintain a healthy lifestyle, a new editorial in the Journal ...
Low diversity of bacteria may increase the risk for asthma
2014-01-07
Low diversity of bacteria may increase the risk for asthma
Low gut microbial diversity in the intestines of infants can increase the risk for asthma development. These are the findings of the age 7 follow-up in a multi-year study led by researchers at ...
Stem cells on the road to specialization
2014-01-07
Stem cells on the road to specialization
Scientists at the University of Copenhagen have gained new insight into how both early embryonic cells and embryonic stem cells are directed into becoming specialised cell types, like pancreatic and liver cells. ...
Drugs related to cannabis have pain-relieving potential for osteoarthritis
2014-01-07
Drugs related to cannabis have pain-relieving potential for osteoarthritis
Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.
These compounds ...
New holographic process uses image-stabilized X-ray camera
2014-01-07
New holographic process uses image-stabilized X-ray camera
This news release is available in German.
The efficiency of the new method is based on a X-ray focussing optics being firmly fixed to the object to ...
First dinosaurs identified from Saudi Arabia
2014-01-07
First dinosaurs identified from Saudi Arabia
Dinosaur fossils are exceptionally rare in the Arabian Peninsula. An international team of scientists from Uppsala University, Museum Victoria, Monash University, and the Saudi Geological Survey have now uncovered the ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] NYSCF scientists make living brain cells from Alzheimer's patients biobanked brain tissueNew study shows ability to make living human cells from biobanked brain tissue